Kelly Michael Aaron
- SEC CIK
- 0001769668
No open-market purchases or sales filed in the past year.
Current role at each company
- PRME Prime Medicine, Inc.Directoras of Jun 8, 2026
- NEO Neogenomics IncDirectoras of Jun 3, 2026
- BOOM DMC Global Inc.Directoras of May 14, 2026
- FOLD Amicus Therapeutics, Inc.Directoras of Apr 27, 2026
- HOOK HOOKIPA Pharma Inc.Directoras of Jul 1, 2022
Show 1 more company
- APRE Aprea Therapeutics, Inc.Directoras of Jul 1, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kelly Michael Aaron as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NEO Neogenomics Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 28, 2025 (view filing) | May 27 | 1 day | Kelly Michael AaronDirector | PPurchase | +5.00K | $7.60 | +$38.0K | New position5.00K after |